CXCL10 and breast carcinoma: Moreover, the correlation of CXCL10 with immune checkpoint blockade (ICB)-related genes has been reported not only in breast cancer but also consistently across 32 other malignancies, including DLBCL (44), highlighting its broad involvement in tumor immune regulation.